Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials
Authors:
Open Access
- 3 January 2017
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 20 (1) , 110-116
Abstract
Background: Methods: Results: Conclusions:Keywords
This publication has 30 references indexed in Scilit:
- Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?Prostate Cancer and Prostatic Diseases, 2016
- Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trialAnnals of Oncology, 2014
- Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trialThe Lancet Oncology, 2014
- Intramedullary nailing for treatment of pathologic femoral fractures due to metastasesInjury, 2014
- A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compressionHealth Technology Assessment, 2013
- Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic ParagangliomaThe Journal of Clinical Endocrinology & Metabolism, 2013
- Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the LiteratureCancer Investigation, 2012
- Oncology Emergency Modules: Spinal Cord CompressionOncology Nursing Forum, 2003
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrumentUrology, 1997